Team:UB Indonesia/backup

From 2014.igem.org

(Difference between revisions)
Line 101: Line 101:
<a href="#background" class="fancybox"><p><i class="icon icon-desktop"></i></p></a>
<a href="#background" class="fancybox"><p><i class="icon icon-desktop"></i></p></a>
<div id="background" style="display:none;width:700px;">
<div id="background" style="display:none;width:700px;">
-
                                        <h2>“A BETTER FUTURE WITH SYNTHETIC BIOLOGY”</h2>
+
<h2><center>“A BETTER FUTURE WITH SYNTHETIC BIOLOGY”</center></h2>
-
<p align="justify">Study of synthetic biology emerged as a multidisciplinary science that help people in solving various problems. Among the general public, synthetic biology is famous as bioengineering and extreme genetic engineering which have an advantage in redesigning a life through genetical circuit, thus allows people to manipulate a new organism for use in treatment and diagnosis of disease, provision of quality seeds, remediation of environmental pollution caused by industrial and mining as well as the mitigation of global warming. <br><br>
+
<p align="justify">Study of synthetic biology emerged as a multidisciplinary science that help people in solving various problems. Among the general public, synthetic biology is famous as bioengineering and extreme genetic engineering which have an advantage in redesigning a life through genetical circuit, thus allows people to manipulate a new organism for use in treatment and diagnosis of disease, provision of quality seeds, remediation of environmental pollution caused by industrial and mining as well as the mitigation of global warming. <br><br>
Indonesia as one of the currently high development countries in science is allowing for synthetic biology to grow rapidly. Prospects for the synthetic biology's development in Indonesia, among others, is the independence of technology in the health sector include the development of a specific diagnosis, the provision of pharmaceutical raw materials, and technology screening for Indonesia natural resources which have potency to treat various types of diseases.<br><br>
Indonesia as one of the currently high development countries in science is allowing for synthetic biology to grow rapidly. Prospects for the synthetic biology's development in Indonesia, among others, is the independence of technology in the health sector include the development of a specific diagnosis, the provision of pharmaceutical raw materials, and technology screening for Indonesia natural resources which have potency to treat various types of diseases.<br><br>
Line 115: Line 115:
<a href="#overview" class="fancybox"><p><i class="icon icon-eye-open"></i></p></a>
<a href="#overview" class="fancybox"><p><i class="icon icon-eye-open"></i></p></a>
                                         <div id="overview" style="display:none;width:700px;">
                                         <div id="overview" style="display:none;width:700px;">
-
<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tea plant (Camelia sinensis) has catechin compounds that contains antioxidants.  Catechin family that most effective used as antioxidant is Epigallocathecin gallate (EGCG).  Based on research in vitro or in silico, EGCG is able to inhibit the proliferation of cancer cells because stop over-expression between L1 HPV 16- EGFR (Epithel Growth Factor Receptor) bond but there are few of EGCG content in tea plant. Based on these problems, we would to over- expression EGCG by knockdown non-compound EGCG gene, so hopefully the content of EGCG on tea are more prominent.  We design siRNA sequence from LAR gene (to inhibit non-EGCG compound) using bioinformatics tool and use P97 promoter to initiate expression in mammalian cell (using HeLa cell). That part will be insert into the psB1C3 linear backbone. To checking performance of this part, we insert sequence target of siRNA into the plasmid Bba_E0240 and get the promoter CMV from Bba_K747096 part. We also prepare for positive control and negative control for this experiment. Positive control part containing siRNA for GFP, insert into Bba_K747096 part that contain CMV promoter, and negative control containing CMV promoter and insert to the Bba_E0240 part containing GFP. Each part will be growth in HeLa cell culture and observed the succeding by fluorescent microscope.</p>
+
<h2><center>“”</center></h2>
 +
<p align="justify"></p>
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Overview</font></h2>
<h2 class="font-thin"><font color="#fff">Overview</font></h2>
Line 121: Line 122:
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-shield"></i></p></a>
+
                                        <a href="#preventing" class="fancybox"><p><i class="icon icon-shield"></i></p></a>
 +
                                        <div id="preventing" style="display:none;width:700px;">
 +
<h2><center>“”</center></h2>
 +
<p align="justify"></p>
 +
                                        </div>
<h2 class="font-thin"><font color="#fff">Preventing</font></h2>
<h2 class="font-thin"><font color="#fff">Preventing</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-stethoscope"></i></p></a>
+
                                        <a href="#screening" class="fancybox"><p><i class="icon icon-stethoscope"></i></p></a>
 +
                                        <div id="screening" style="display:none;width:700px;">
 +
<h2><center>“”</center></h2>
 +
<p align="justify"></p>
 +
                                        </div>
<h2 class="font-thin"><font color="#fff">Screening</font></h2>
<h2 class="font-thin"><font color="#fff">Screening</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
Line 134: Line 143:
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-medkit"></i></p></a>
+
<a href="#therapy" class="fancybox"><p><i class="icon icon-medkit"></i></p></a>
 +
                                        <div id="therapy" style="display:none;width:700px;">
 +
<h2><center>“”</center></h2>
 +
<p align="justify"></p>
 +
                                        </div>
<h2 class="font-thin"><font color="#fff">Therapy</font></h2>
<h2 class="font-thin"><font color="#fff">Therapy</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>

Revision as of 07:08, 16 October 2014

iGEM2014 | UB INDONESIA

BRAWIJAYA UNIVERSITY , INDONESIA

This is team wiki to share our iGEM experience



iGEM UB
BRAWIJAYA UNIVERSITY
iGEM2014
PROJECT
 
Abstract ...

Background

Detail.

Overview

Detail.

Preventing

Detail.

Screening

Detail.

Therapy

Detail.

NOTEBOOK
 
Description

Timeline

Detail.

Lab Journal

Detail.

Method

Detail.

HUMAN PRACTICE
 
Teks description

Workshop

Education

Society

COLLABORATIONS
 
Description

Timeline

Lab Journal

Method

PARTS
 
Description

Submitted Parts

Favorite Parts

ABOUT US
 
Description

Members

Sponsors

Attributions

Leave us a message
 
You can find us literally anywhere,

just push a button and we’re there

in/igemub

igemub@gmail.com

Malang, Indonesia
zip code 65145

facebook/igembrawijaya

@igem_ub